Chlamydia screening in primary care: is it useful, affordable and universal?
Genital chlamydial infection, with its possible long-term morbidity, is a serious public health problem. The number of new diagnoses is rising rapidly and, in the UK, recent evidence suggests that the infection rate in young women exceeds 10%. Screening programmes can reduce the population prevalence of infection, but uncertainty remains as to the ideal screening model. This may prove to be opportunistic screening of sexually active young women, less than 25 years of age, in primary care settings, and contact tracing of the partners of those with chlamydia. Recent literature on the practicalities of genital chlamydia screening is reviewed.
Tobin
Jean M
JM
Department of Genitourinary Medicine, St Mary's Hospital, Milton Road, Portsmouth, Hampshire PO3 6AD, UK. jean.tobin@smail01.porthosp.swest.nhs.uk
D002690:Chlamydia Infections / Q000175:diagnosis* / Q000191:economics / Q000382:microbiology; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000191:economics / Q000379:methods / Q000706:statistics & numerical data; D015995:Prevalence; D011320:Primary Health Care / Q000191:economics / Q000379:methods / Q000706:statistics & numerical data; D012307:Risk Factors